Opportunity Overview
health, white adipose tissue (WAT) is an essential metabolic buffer, safely storing and supplying energy according to intake
and metabolic demand. As obesity develops, expansion of the WAT beds accommodates excess lipid storage. However,
profound adipocyte hypertrophy and WAT expansion ultimately drive tissue hypoxia, adipocyte dysfunction, immune cell
infiltration, and tissue fibrosis. This is especially evident in visceral WAT depots, and the degree of visceral adiposity is
associated with poor metabolic outcomes (e.g. insulin resistance) in humans and animal models. Despite many decades of
research, the events which trigger a transition from safe and efficient fat storage to tissue dysfunction remain a subject of
debate. It is well recognised that aberrant WAT function during obesity is a prominent feature of compromised metabolic
health. Here, attenuated metabolic activity, endocrine function and adipogenic capacity of WAT reduces healthy metabolic
profile, and progression to WAT inflammation and fibrosis elevates risk for pathologies such as diabetes and cancer. We have
identified the nuclear hormone receptor, NR1D1, as a major regulator of adipose tissue, whereby selective deletion of this
factor in adipocytes prevents development of WAT inflammation and fibrosis even amid profound obesity1
. In work leading
up to this PhD proposal, components extracellular matrix (ECM) have emerged as clear regulatory target of NR1D1 activity in
adipocytes, and we propose that altered collagen dynamics underlie the 'healthy' obese phenotype driven by Nr1d1 deletion.
Adipocytes are embedded in an ECM that must allow tissue expansion and regression, but also provide structural support for
relatively fragile lipid laden adipocytes. Critical here is the tissue and metabolic-state specific expression ECM proteins such
as collagens and their...
This is one of 1,833 active United Kingdom Research Development opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | BBSRC |
|---|---|
| Country | United Kingdom |
| Category | Research Development |
| Published | September 30, 2024 |
| Procurement stage | Active solicitation |
| Response due | September 29, 2028 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 09, 2026 |
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
Related Opportunities in United Kingdom
See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United Kingdom Research Development intelligence report in your inbox
A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.